Literature DB >> 5011668

Rifampin in treatment of advanced pulmonary tuberculosis. Report of a VA cooperative pilot study.

J W Raleigh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5011668     DOI: 10.1164/arrd.1972.105.3.397

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  7 in total

Review 1.  Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.

Authors:  M Zierski
Journal:  Lung       Date:  1977       Impact factor: 2.584

Review 2.  New trends in the chemotherapy of tuberculosis--current aspects.

Authors:  M Zierski
Journal:  Pneumonologie       Date:  1974-06-14

3.  Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo.

Authors:  M Huppert; D Pappagianis; S H Sun; I Gleason-Jordan; M S Collins; K R Vukovich
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

4.  Tuberculous peritonitis: 43 years' expereince in diagnosis and treatment.

Authors:  P Dineeen; W P Homan; W R Grafe
Journal:  Ann Surg       Date:  1976-12       Impact factor: 12.969

5.  Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice.

Authors:  A Agarwal; H Kandpal; H P Gupta; N B Singh; C M Gupta
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  Effect of rifampin on the immune response in guinea pigs.

Authors:  B M Dajani; J E Kasik; J S Thompson
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

7.  Effect of rifampin on cutaneous hypersensitivity to purified protein derivative in humans.

Authors:  P Mukerjee; S Schuldt; J E Kasik
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.